奥精医疗: directors' dealings · France · AMF SSE:688613 FR FR · AMF Mcap 2.8Bn€
Explore the full directors' dealings record of 奥精医疗, a listed equity based in France. Shares are quoted on FR FR, under the authority of AMF. Market capitalisation: €2.8bn. The latest transaction was filed on 31 December 2025 — Sale. Among the most active insiders: 宋天喜. Every trade is openly available.
Financial data FY ended December 2025 · cache
Income statement
Revenue 223.7 M€
Gross profit 153.6 M€ 69% margin
Net income 13.8 M€ 6.2% margin
Balance sheet & cash
Market cap 2.78 Bn€
Total debt 47.9 M€
Free Cash Flow 10.6 M€
Last declaration on 31 December 2025
Declarations 12 total
Executives ● Sale11 SSE
5,000 shares
SSE:273000000077323000 · 31 Dec 2025
Executives ● Sale7 SSE
10,000 shares
SSE:273000000077323070 · 31 Dec 2025
Executives ● Sale11 SSE
2,500 shares
SSE:273000000073774560 · 29 Dec 2025
Executives ● Sale7 SSE
15,000 shares
SSE:273000000052853500 · 22 Dec 2025
Executives ● Sale7 SSE
50,000 shares
SSE:273000000052853570 · 22 Dec 2025
Executives ● Sale7 SSE
5,000 shares
SSE:273000000042618270 · 19 Dec 2025
Executives ● Sale7 SSE
32,500 shares
SSE:273000000025875800 · 15 Dec 2025
Executives ● Sale7 SSE
10,000 shares
SSE:273000000013135360 · 10 Dec 2025
Executives ● Sale7 SSE
10,000 shares
SSE:273000000013135500 · 10 Dec 2025
Executives ● Sale7 SSE
10,000 shares
SSE:273000000008960160 · 9 Dec 2025
Executives ● Sale11 SSE
2,000 shares
SSE:273000000008960200 · 9 Dec 2025
Executives ● Purchase11 SSE
115,000 shares
SSE:173000008891591500 · 29 Apr 2025
Ideal exit: 24 Jan 2026 (T+270)